Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Specialty Chemicals
Lonza consolidates its New Jersey R&D
by Marc S. Reisch
June 3, 2018
| A version of this story appeared in
Volume 96, Issue 23
Credit: Lonza
Lonza's new site in Morristown, N.J.
Lonza plans to close two New Jersey sites—in South Plainfield and Allendale—that came with its 2011 purchase of Arch Chemicals. Employees will move to a site in Morristown, N.J., that Lonza acquired with its 2017 purchase of Capsugel, says Jeff Rogers, consumer products vice president. Many of the 130-plus employees affected by the move are with Lonza’s consumer care unit. About 40 are cosmetic chemists who will move into a new Morristown lab in early 2019.
Chemical & Engineering News
ISSN 0009-2347
Copyright © 2025 American Chemical Society
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X